Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human MAP3K1 Stable Cell Line

    [CAT#: S01YF-1123-KX291]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1201 Magic™ Human MAP3K1 in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    MAP3K1
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    4T1; CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Reproductive Research
    Related Diseases
    46,Xy Sex Reversal 6 and 46,Xy Partial Gonadal Dysgenesis. Among its related pathways are MyD88 dependent cascade initiated on endosome and TNFR1 Pathway
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The autosomal MAP3K1 gene in humans encodes the signal transduction enzyme mitogen-activated protein kinase kinase 1 (MAP3K1). As a ubiquitin ligase and serine/threonine kinase, MAP3K1 is essential to a network of enzymes that integrates cellular receptor responses to various mitogenic and metabolic stimuli. It is possible that the MAP3K1 kinase domain functions as a mild stimulator of IκB kinase activity. A ubiquitin-conjugating enzyme that has been loaded with ubiquitin is recruited by the MAP3K1 E3 ubiquitin ligase. The enzyme then interacts with its substrates and helps transfer ubiquitin from the enzyme to its substrates. According to genetics, MAP3K1 plays a significant role in the development of embryos, cancer, cell proliferation, migration, cytokine production, and humoral immunity. The customized MAP3K1 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Jessica

    The affinity is very good and I definitely recommend this MAP3K1 cell line. Jan 13 2021

    chat Verified Customer

    chat Deborah

    We are satisfied with this human MAP3K1 cell line and we will use it in our experimental projects. Dec 12 2021

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Transfection of Map3k1 amiRNA significantly impaired cellular level of MEKK1.

    4T1 cells were transfected using the constructs. The highest interference efficiency was attained by Map3k1 amiRNA-3 by real-time PCR analysis. The transfection of Map3k1 amiRNA-3 resulted in a significant down-regulation of the MEKK1 protein level, as anticipated.

    Ref: Liu, Chun, et al. "MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro." Springerplus 5 (2016): 1-12.

    Pubmed: 26759750

    DOI: 10.1186/s40064-015-1597-z

    Research Highlights

    Numerous sex-determining genes have been found through research into diseases of sex development (DSD). Encoding a signal transduction regulator in the process of sex determination, MAP3K1 is becoming known as one of the more prevalent genes causing 46,XY DSD, which manifests as either total or partial gonadal dysgenesis.
    Granados, Andrea, et al. "MAP3K1-related gonadal dysgenesis: Six new cases and review of the literature." American Journal of Medical Genetics Part C: Seminars in Medical Genetics. Vol. 175. No. 2. 2017.
    Pubmed: 28504475   DOI: 10.1002/ajmg.c.31559

    In luminal A BrCa samples, activating mutations of PIK3CA (~45%) are commonly seen. In luminal A BrCa samples, genomic analyses have revealed inactivating mutations in two upstream kinases of the JNK apoptotic pathway, MAP3K1 (13-20%) and MAP2K4 (~8%).
    Avivar-Valderas, Alvaro, et al. "Functional significance of co-occurring mutations in PIK3CA and MAP3K1 in breast cancer." Oncotarget 9.30 (2018): 21444.
    Pubmed: 29765551   DOI: 10.18632/oncotarget.25118

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare